New wave of lung disease among renovators

Research into a treatment for asbestosis and mesothelioma is showing promising results, and has real potential to short-circuit the progression of the disease, says a Sydney microbiologist.

Associate Professor Tony George and his co-researchers have discovered a compound they hope will be developed into a puffer-administered medication to treat the growing number of Australians diagnosed with incurable asbestos-related lung disease.

The team has found that the compound stopped the development of mesothelioma tumours in 60-80 per cent of asbestos-exposed mice in 30-week laboratory trials.

You can read more about this latest research on the website at: http://www.smh.com.au/brand-discover/scroll/brink/10/compound/